BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Federal Trade Commission
Cerilliant
Moodys
AstraZeneca
Fuji
Daiichi Sankyo
Covington
Boehringer Ingelheim

Which drugs have the most supplementary protection certificates?

This chart shows the drugs with the most supplementary protection certificates (SPCs).

SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to obtain regulatory approval for drugs. SPCs come into force only after the corresponding general patent expires, and normally have a maximum lifetime of 5 years.

The total combined duration of market exclusivity of a general patent and SPC cannot normally exceed 15 years, but a six-month extention may be obtained by responding to a request for pediatric trials.

The pharmaceutical drugs with the most SPCs are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing

botpot